FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale.
Adam P, Kircher S, Sbiera I, Koehler VF, Berg E, Knösel T, Sandner B, Fenske WK, Bläker H, Smaxwil C, Zielke A, Sipos B, Allelein S, Schott M, Dierks C, Spitzweg C, Fassnacht M, Kroiss M.
Adam P, et al. Among authors: koehler vf.
Front Endocrinol (Lausanne). 2021 Aug 12;12:712107. doi: 10.3389/fendo.2021.712107. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 34475850
Free PMC article.